Williams Jones & Associates LLC reduced its position in Henry Schein, Inc. (NASDAQ:HSIC) by 6.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,469 shares of the company’s stock after selling 1,310 shares during the quarter. Williams Jones & Associates LLC’s holdings in Henry Schein were worth $3,563,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in shares of Henry Schein by 3.0% in the 2nd quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock valued at $1,479,959,000 after buying an additional 236,862 shares in the last quarter. FMR LLC lifted its holdings in shares of Henry Schein by 0.4% during the 2nd quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after acquiring an additional 24,935 shares during the period. BlackRock Inc. lifted its holdings in shares of Henry Schein by 1.8% during the 2nd quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after acquiring an additional 101,406 shares during the period. State Street Corp lifted its holdings in shares of Henry Schein by 1.3% during the 1st quarter. State Street Corp now owns 3,675,674 shares of the company’s stock worth $624,760,000 after acquiring an additional 48,469 shares during the period. Finally, Mackenzie Financial Corp lifted its holdings in shares of Henry Schein by 4.7% during the 1st quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock worth $293,747,000 after acquiring an additional 76,794 shares during the period. 44.52% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts recently issued reports on HSIC shares. Piper Jaffray Companies upgraded shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research report on Friday, September 15th. Jefferies Group LLC restated a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research report on Friday, July 21st. Royal Bank Of Canada initiated coverage on shares of Henry Schein in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 price objective for the company. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Finally, Stifel Nicolaus restated a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and seven have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $92.85.

In related news, SVP Paul Rose sold 2,126 shares of the company’s stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the completion of the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.27% of the company’s stock.

Shares of Henry Schein, Inc. (NASDAQ HSIC) traded up 0.21% during trading on Tuesday, reaching $81.20. The company’s stock had a trading volume of 249,057 shares. The stock has a market cap of $12.84 billion, a P/E ratio of 23.73 and a beta of 1.09. Henry Schein, Inc. has a 12-month low of $73.11 and a 12-month high of $93.50. The stock’s 50-day moving average is $83.87 and its 200-day moving average is $87.68.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.02. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.82 EPS. Equities research analysts anticipate that Henry Schein, Inc. will post $3.64 earnings per share for the current fiscal year.

Henry Schein declared that its Board of Directors has approved a share repurchase plan on Monday, September 18th that allows the company to buyback $400.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 6.3% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s board of directors believes its shares are undervalued.

TRADEMARK VIOLATION NOTICE: “Williams Jones & Associates LLC Has $3.56 Million Holdings in Henry Schein, Inc. (HSIC)” was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/williams-jones-associates-llc-has-3-56-million-holdings-in-henry-schein-inc-hsic/1605604.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.